• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is it possible to survive pancreatic cancer?

作者信息

Löhr Matthias

机构信息

University of Heidelberg, Heidelberg, Germany.

出版信息

Nat Clin Pract Gastroenterol Hepatol. 2006 May;3(5):236-7. doi: 10.1038/ncpgasthep0469.

DOI:10.1038/ncpgasthep0469
PMID:16672986
Abstract
摘要

相似文献

1
Is it possible to survive pancreatic cancer?
Nat Clin Pract Gastroenterol Hepatol. 2006 May;3(5):236-7. doi: 10.1038/ncpgasthep0469.
2
Increasing survival rates of patients with pancreatic cancer by earlier identification.通过早期识别提高胰腺癌患者的生存率。
Nat Clin Pract Oncol. 2006 Jul;3(7):346-7. doi: 10.1038/ncponc0483.
3
Identification of early-stage pancreatic cancer biomarkers.早期胰腺癌生物标志物的鉴定。
Expert Rev Mol Diagn. 2008 Nov;8(6):675. doi: 10.1586/14737159.8.6.675.
4
[The status of early detection of pancreatic cancer].[胰腺癌的早期检测现状]
Internist (Berl). 1989 Nov;30(11):752-8.
5
Tumor M2-pyruvate kinase and pancreatic cancer.
Pancreas. 2008 Aug;37(2):221-2; author reply 222. doi: 10.1097/MPA.0b013e3181619a45.
6
Diagnostic and prognostic value of plasma tumor M2 pyruvate kinase in periampullary cancer: evidence for a novel biological marker of adverse prognosis.血浆肿瘤M2丙酮酸激酶在壶腹周围癌中的诊断和预后价值：不良预后新生物标志物的证据
Pancreas. 2007 Apr;34(3):318-24. doi: 10.1097/MPA.0b013e31802ee9c7.
7
[The prognostic value of CA 19-9 in the preoperative work-up of pancreatic cancer patients].
Harefuah. 2006 Nov;145(11):793-4, 863.
8
Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer.肿瘤标志物M2-丙酮酸激酶在慢性胰腺炎与胰腺癌鉴别诊断中的应用
Hepatogastroenterology. 2008 Jul-Aug;55(85):1475-7.
9
Caveolin-1: a marker for pancreatic cancer diagnosis.小窝蛋白-1：一种用于胰腺癌诊断的标志物。
Expert Rev Mol Diagn. 2008 Jul;8(4):395-404. doi: 10.1586/14737159.8.4.395.
10
Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.血清肿瘤标志物、粪便k-ras和p53基因突变对胰腺癌的诊断价值评估。
Chin J Dig Dis. 2006;7(3):170-4. doi: 10.1111/j.1443-9573.2006.00263.x.

引用本文的文献

1
Expression of SMURF family in pancreatic cancer and its effect on cell proliferation and migration.SMURF家族在胰腺癌中的表达及其对细胞增殖和迁移的影响。
Front Oncol. 2025 Apr 24;15:1538335. doi: 10.3389/fonc.2025.1538335. eCollection 2025.
2
Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer.局部晚期和转移性胰腺癌患者不同治疗顺序的生存结局。
BMC Cancer. 2024 Jan 12;24(1):67. doi: 10.1186/s12885-024-11823-8.
3
A composite indicator of derived neutrophil-lymphocyte ratio and lactate dehydrogenase correlates with outcomes in pancreatic carcinoma patients treated with PD-1 inhibitors.
衍生中性粒细胞与淋巴细胞比值和乳酸脱氢酶的综合指标与接受PD-1抑制剂治疗的胰腺癌患者的预后相关。
Front Oncol. 2022 Oct 25;12:951985. doi: 10.3389/fonc.2022.951985. eCollection 2022.
4
Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights.免疫疗法联合胰腺癌成熟治疗策略：当前见解
Cancer Manag Res. 2022 Mar 8;14:1043-1061. doi: 10.2147/CMAR.S267260. eCollection 2022.
5
Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma.液体活检作为胰腺导管腺癌管理的预后和治疗诊断工具
Front Med (Lausanne). 2022 Jan 14;8:788869. doi: 10.3389/fmed.2021.788869. eCollection 2021.
6
Two Antibody-Guided Lactic-co-Glycolic Acid-Polyethylenimine (LGA-PEI) Nanoparticle Delivery Systems for Therapeutic Nucleic Acids.用于治疗性核酸的两种抗体导向乳酸-乙醇酸共聚物-聚乙烯亚胺（LGA-PEI）纳米颗粒递送系统
Pharmaceuticals (Basel). 2021 Aug 25;14(9):841. doi: 10.3390/ph14090841.
7
Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma.上皮-间质转化在胰腺导管腺癌化疗耐药中的作用
World J Clin Cases. 2021 Jul 6;9(19):4998-5006. doi: 10.12998/wjcc.v9.i19.4998.
8
Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer.胰腺癌诊断、预后及预测生物标志物的最新发现
Cancers (Basel). 2020 Nov 2;12(11):3234. doi: 10.3390/cancers12113234.
9
Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer.基于生物信息学的下一代测序数据分析在胰腺癌精准医疗中的应用。
Mol Oncol. 2017 Oct;11(10):1413-1429. doi: 10.1002/1878-0261.12108. Epub 2017 Aug 8.
10
Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics.通过液相色谱-质谱联用代谢组学鉴别胰腺癌和胰腺炎
Metabolomics. 2017;13(5):61. doi: 10.1007/s11306-017-1199-6. Epub 2017 Apr 1.